Latest News

MMS Named a Great Place to Work in India

BANGALORE, India (1/12/2023) – MMS Holdings, a data-focused contract research organization (CRO), has been named a Great Place to Work by the Great Place to Work Institute of India.

This award is based on anonymous feedback from a survey sent out to employees and measures the quality of employee experience, the strength of leadership, the quality of the practices and programs that shape employee experience, and the levels of trust that enable everyone to use their potential. 

Over 87% of MMS employees completed the survey, and based on their feedback, MMS was recognized as demonstrating the excellent workplace culture needed for success.

“We are honored to be named a Great Place to Work in India, especially because our colleagues determined the result,” said Uma Sharma, Ph.D., Chief Executive Officer at MMS. “Our colleagues in India play a key role in our global #OneMMS strength, and it is through their embodiment of our core values and mission that we achieve success.”

“We wouldn’t have achieved this recognition without our dedicated leaders at all levels,” said Uma Nathan, Executive Head of India Operations at MMS. “The strength of our #OneMMS team is the help we extend to our colleagues across the globe, so we can focus on solutions and making a difference in the lives of patients.”

“MMS continues to strive to provide the best work culture to our colleagues,” said Nandini Vijaisimha, Director of Human Resources at MMS. “We believe in nurturing a creative environment and helping our colleagues by establishing a culture where people can be innovative.”

About MMS

MMS Holdings (MMS) is an innovative, data-focused CRO that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, including offices in Bangalore and Hyderabad, MMS maintains one of the highest retention rates in the industry.

Media Contact

Prakash Achaary

media@mmsholdings.com

Suggested For You

news

July 17th, 2024

Industry Veteran Ben Dudley Joins MMS as Chief Commercial Officer (CCO) to Drive Continued Growth for the Data-focused Clinical Research Organization

news

April 4th, 2024

MMS Hires Pharmaceutical Industry Veteran James Zee for Global Biometrics Leadership in Europe Amid Strong Regional Growth

news

March 6th, 2024

MMS Holdings Inc – A Data-Centric CRO Powerhouse Reshaping Drug Development on a Global Scale

news

December 13th, 2023

MMS Supported Lykos Therapeutics: NDA Submitted to FDA for First Psychedelic-Assisted Therapy for PTSD

news

April 18th, 2023

MMS Named Great Place to Work in the UK as Growth in the Region Doubles

news

March 21st, 2023

MMS Scientific Advisory Board’s New Members Expand CRO’s Therapeutic Expertise

news

February 21st, 2023

MMS Partners with I-ACT to Advance Children’s Clinical Trials

news

February 7th, 2023

Award-Winning Data CRO Expands Executive Leadership to Support Company’s Next Stage of Growth

news

November 21st, 2022

MMS Named Michigan Top Workplace For The Second Consecutive Year

news

August 16th, 2022

Together Trial with EDC Database Designed by MMS Wins Trial of the Year

news

June 28th, 2022

MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth

news

June 27th, 2022

Novel PTSD Treatment Advances Toward Regulatory Evaluation with New Collaboration Between MAPS PBC and MMS Holdings